Mark Murray
2018 - Arbutus Biopharma Corp
In 2018, Mark Murray earned a total compensation of $2.5M as President and Chief Executive Officer at Arbutus Biopharma Corp, a 32% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $306,000 |
|---|---|
| Option Awards | $1,610,020 |
| Salary | $556,000 |
| Other | $55,865 |
| Total | $2,527,885 |
Murray received $1.6M in option awards, accounting for 64% of the total pay in 2018.
Murray also received $306K in non-equity incentive plan, $556K in salary and $55.9K in other compensation.
Rankings
In 2018, Mark Murray's compensation ranked 4,617th out of 14,244 executives tracked by ExecPay. In other words, Murray earned more than 67.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,617 out of 14,244 | 68th |
Division Manufacturing | 1,733 out of 5,759 | 70th |
Major group Chemicals And Allied Products | 624 out of 2,122 | 71st |
Industry group Drugs | 522 out of 1,811 | 71st |
Industry Pharmaceutical Preparations | 402 out of 1,385 | 71st |
Source: SEC filing on April 23, 2019.
Murray's colleagues
We found two more compensation records of executives who worked with Mark Murray at Arbutus Biopharma Corp in 2018.
News
Jones Soda CEO David Knight receives $1.4M in 2023
April 3, 2024
Jones Soda CEO Mark Murray's 2022 pay rises 5% to $406K
April 5, 2023
Jones Soda CEO Mark Murray's 2021 pay jumps 58% to $386K
April 1, 2022
Jones Soda CEO Mark Murray's 2020 pay falls 94% to $243K
April 1, 2021
Arbutus Biopharma Corp CEO Mark Murray's 2019 pay jumps 50% to $3.8M
April 24, 2020
Arbutus Biopharma Corp CEO Mark Murray's 2018 pay jumps 32% to $2.5M
April 23, 2019